Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBIT Multiple | -20.7x - -22.9x | -21.8x |
Selected Fwd EBIT Multiple | -12.0x - -13.2x | -12.6x |
Fair Value | ₩1,673 - ₩1,811 | ₩1,742 |
Upside | -38.1% - -33.1% | -35.6% |
Benchmarks | Ticker | Full Ticker |
The Technology Co.,Ltd. | A043090 | KOSDAQ:A043090 |
Celemics, Inc. | A331920 | KOSDAQ:A331920 |
Hyundai ADM Bio Inc. | A187660 | KOSDAQ:A187660 |
HLB bioStep Co.,Ltd. | A278650 | KOSDAQ:A278650 |
NanoEntek, Inc. | A039860 | KOSDAQ:A039860 |
Green Lifescience Co., Ltd. | A114450 | KOSDAQ:A114450 |
- | - | - |
Select LTM EBIT Multiple | |||||||
Benchmark Companies | |||||||
A043090 | A331920 | A187660 | A278650 | A039860 | A114450 | ||
KOSDAQ:A043090 | KOSDAQ:A331920 | KOSDAQ:A187660 | KOSDAQ:A278650 | KOSDAQ:A039860 | KOSDAQ:A114450 | ||
Historical EBIT Growth | |||||||
5Y CAGR | NM- | NM- | NM- | NM- | -27.3% | -8.6% | |
3Y CAGR | NM- | NM- | NM- | NM- | -50.9% | NM- | |
Latest Twelve Months | 52.4% | 62.4% | -737.0% | -193.8% | 143.3% | 48.3% | |
Historical EBIT Profit Margin | |||||||
5 Year Average Margin | -100.9% | -56.4% | -24.6% | 2.7% | 6.8% | -11.2% | |
Prior Fiscal Year | -128.4% | -87.7% | -13.9% | -2.2% | -8.3% | -20.8% | |
Latest Fiscal Year | -96.2% | -28.3% | -164.1% | -22.4% | 2.0% | 1.5% | |
Latest Twelve Months | -90.5% | -27.7% | -164.1% | -22.0% | 2.5% | -6.4% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 0.52x | 0.52x | 5.31x | 1.38x | 2.65x | 2.04x | |
EV / LTM EBITDA | -0.7x | -3.3x | -3.6x | -10.0x | 23.4x | -66.0x | |
EV / LTM EBIT | -0.6x | -1.9x | -3.2x | -6.3x | 107.3x | -32.0x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBIT | -6.3x | -1.9x | 107.3x | ||||
Historical EV / LTM EBIT | -250.8x | -22.9x | -7.6x | ||||
Selected EV / LTM EBIT | -20.7x | -21.8x | -22.9x | ||||
(x) LTM EBIT | (1,480) | (1,480) | (1,480) | ||||
(=) Implied Enterprise Value | 30,650 | 32,263 | 33,876 | ||||
(-) Non-shareholder Claims * | 7,184 | 7,184 | 7,184 | ||||
(=) Equity Value | 37,834 | 39,447 | 41,061 | ||||
(/) Shares Outstanding | 19.5 | 19.5 | 19.5 | ||||
Implied Value Range | 1,937.62 | 2,020.24 | 2,102.85 | ||||
FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
Implied Value Range (Trading Cur) | 1,937.62 | 2,020.24 | 2,102.85 | 2,705.00 | |||
Upside / (Downside) | -28.4% | -25.3% | -22.3% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | A043090 | A331920 | A187660 | A278650 | A039860 | A114450 | |
Enterprise Value | 5,222 | 2,989 | 50,770 | 82,044 | 82,996 | 45,634 | |
(+) Cash & Short Term Investments | 1,379 | 9,235 | 5,843 | 37,233 | 33,089 | 12,512 | |
(+) Investments & Other | 3,292 | 13,230 | 2,041 | 38,807 | 24 | 0 | |
(-) Debt | (5,341) | (431) | (9,288) | (29,855) | (352) | (5,328) | |
(-) Other Liabilities | 167 | (0) | 194 | (4,733) | 0 | 0 | |
(-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 4,719 | 25,023 | 49,559 | 123,496 | 115,757 | 52,818 | |
(/) Shares Outstanding | 12.4 | 8.2 | 42.3 | 84.5 | 32.1 | 19.5 | |
Implied Stock Price | 380.00 | 3,065.00 | 1,172.00 | 1,462.00 | 3,605.00 | 2,705.00 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 380.00 | 3,065.00 | 1,172.00 | 1,462.00 | 3,605.00 | 2,705.00 | |
Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |